145872-60-2

Upstream product

• 77472-39-0 (3-nitrophenyl)methanethiol 
• 107-07-3 2-chloro-ethanol 
• 118695-72-0 2-(3-nitro-phenylmethanesulfonyl)-ethanol 

Downstream Products

• 1403988-55-5 2-({3-[(4-chloro-1,3,5-triazin-2-yl)amino]benzyl}sulfonyl)ethanol 
• 1073589-58-8 2-{3-[4-(2-methoxy-phenyl)-pyrimidin-2-ylamino]-phenylmethanesulfonyl}-ethanol 

Relevant academic research and scientific papers

SUBSTITUTED 4-ARYL-N-PHENYL-1,3,5-TRIAZIN-2-AMINES

The present invention relates to substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-amines of general formula (I) as described and defined herein, and methods for their preparation, their use for the treatment and/or prophylaxis of disorders, in particular of hy

INHIBITORS OF PROTEIN KINASES

The present invention relates to inhibitors of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to methods of preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases comprising the administration of an effective amount of at least one inhibitor of cyclin-dependent kinases.

INHIBITORS OF PROTEIN KINASES

The present invention relates to inhibitors of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to methods of preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases comprising the administration of an effective amount of at least one inhibitor of cyclin-dependent kinases.